Literature DB >> 25018040

Excitatory drive onto dopaminergic neurons in the rostral linear nucleus is enhanced by norepinephrine in an α1 adrenergic receptor-dependent manner.

Megan A Williams1, Chia Li2, Thomas L Kash3, Robert T Matthews4, Danny G Winder5.   

Abstract

Dopaminergic innervation of the extended amygdala regulates anxiety-like behavior and stress responsivity. A portion of this dopamine input arises from dopamine neurons located in the ventral lateral periaqueductal gray (vlPAG) and rostral (RLi) and caudal linear nuclei of the raphe (CLi). These neurons receive substantial norepinephrine input, which may prime them for involvement in stress responses. Using a mouse line that expresses eGFP under control of the tyrosine hydroxylase promoter, we explored the physiology and responsiveness to norepinephrine of these neurons. We find that RLi dopamine neurons differ from VTA dopamine neurons with respect to membrane resistance, capacitance and the hyperpolarization-activated current, Ih. Further, we found that norepinephrine increased the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) on RLi dopamine neurons. This effect was mediated through the α1 adrenergic receptor (AR), as the actions of norepinephrine were mimicked by the α1-AR agonist methoxamine and blocked by the α1-AR antagonist prazosin. This action of norepinephrine on sEPSCs was transient, as it did not persist in the presence of prazosin. Methoxamine also increased the frequency of miniature EPSCs, indicating that the α1-AR action on glutamatergic transmission likely has a presynaptic mechanism. There was also a modest decrease in sEPSC frequency with the application of the α2-AR agonist UK-14,304. These studies illustrate a potential mechanism through which norepinephrine could recruit the activity of this population of dopaminergic neurons.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dopamine; Excitatory transmission; Extended amygdala; Norepinephrine; Rostral linear nucleus

Mesh:

Substances:

Year:  2014        PMID: 25018040      PMCID: PMC4188726          DOI: 10.1016/j.neuropharm.2014.07.001

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  53 in total

1.  Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat.

Authors:  Renata H Hasue; Sara J Shammah-Lagnado
Journal:  J Comp Neurol       Date:  2002-12-02       Impact factor: 3.215

2.  Neurochemical changes in mice following physical or psychological stress exposures.

Authors:  Den'etsu Sutoo; Kayo Akiyama
Journal:  Behav Brain Res       Date:  2002-08-21       Impact factor: 3.332

3.  Priming of excitatory synapses by alpha1 adrenoceptor-mediated inhibition of group III metabotropic glutamate receptors.

Authors:  Grant R J Gordon; Jaideep S Bains
Journal:  J Neurosci       Date:  2003-07-16       Impact factor: 6.167

4.  Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies.

Authors:  E D Abercrombie; R W Keller; M J Zigmond
Journal:  Neuroscience       Date:  1988-12       Impact factor: 3.590

5.  Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus.

Authors:  J Korf; G K Aghajanian; R H Roth
Journal:  Neuropharmacology       Date:  1973-10       Impact factor: 5.250

6.  Divergent effects of putative anxiolytics on stress-induced fos expression in the mesoprefrontal system of the rat.

Authors:  B A Morrow; J D Elsworth; E J Lee; R H Roth
Journal:  Synapse       Date:  2000-05       Impact factor: 2.562

7.  Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex.

Authors:  E D Abercrombie; K A Keefe; D S DiFrischia; M J Zigmond
Journal:  J Neurochem       Date:  1989-05       Impact factor: 5.372

8.  Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons.

Authors:  Mark A Ungless; Vineeta Singh; Tara L Crowder; Rami Yaka; Dorit Ron; Antonello Bonci
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

9.  Dopamine decreases NMDA currents in the oval bed nucleus of the stria terminalis of cocaine self-administering rats.

Authors:  Michal Krawczyk; Julian deBacker; Xenos Mason; Andrea A Jones; Eric C Dumont
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-01-26       Impact factor: 5.067

10.  Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress.

Authors:  Marco Cecchi; Habibeh Khoshbouei; David A Morilak
Journal:  Neuropharmacology       Date:  2002-12       Impact factor: 5.250

View more
  3 in total

Review 1.  Specificity and impact of adrenergic projections to the midbrain dopamine system.

Authors:  Carlos A Mejias-Aponte
Journal:  Brain Res       Date:  2016-01-26       Impact factor: 3.252

2.  Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal.

Authors:  Kirsten A Porter-Stransky; Samuel W Centanni; Saumya L Karne; Lindsay M Odil; Sinda Fekir; Jennifer C Wong; Canaan Jerome; Heather A Mitchell; Andrew Escayg; Nigel P Pedersen; Danny G Winder; Darlene A Mitrano; David Weinshenker
Journal:  Biol Psychiatry       Date:  2018-08-17       Impact factor: 13.382

3.  Regulation of cocaine seeking behavior by locus coeruleus noradrenergic activity in the ventral tegmental area is time- and contingency-dependent.

Authors:  Wojciech B Solecki; Michał Kielbinski; Michał Wilczkowski; Katarzyna Zajda; Karolina Karwowska; Bernacka Joanna; Zenon Rajfur; Ryszard Przewłocki
Journal:  Front Neurosci       Date:  2022-08-05       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.